Prior studies have also observed that high RUNX2 expression in kidney cancer is associated with a mesenchymal phenotype which promotes tumour cell migration, invasion and proliferation in vitro, and with higher tumour grade in vivo69–71. Here, RUNX2 is linked to kidney cancer.